4 Biotech Stocks That More Than Doubled This Year
December 23, 2017 at 19:50 PM EST
The biotech industry has been on the comeback trail in 2017 after facing challenges including pricing pressure, rising competition, pipeline setbacks, pricing pressure, slowdown in growth of mature products and generic competition for key drugs.